COVID-19 Updates: Cholesterol Medication and Mortality, Stronger Immunity in Women

Statin Use and Mortality
According to a meta-analysis of four studies examining retrospective data, statin (cholesterol medication) use mitigates the severe or fatal course of COVID-19. The study included approximately 9000 COVID-19 patients, comparing groups who did and did not use statins. It found that the risk of death or severe COVID-19 in statin users was approximately 30% lower. The researchers emphasize that the results refute concerns that statin use harms patients with COVID-19.
Stressing once again that further research is needed to confirm the findings, the researchers suggest that moderate- to high-intensity statin therapy may be beneficial for patients with COVID-19 in the meantime.
Women Have Stronger Immunity
Since the early days of the coronavirus outbreak, older men have been known to have higher risks of illness and death than older women. Nature published a study suggesting that this might be because women mount a stronger immune response than men. The findings show that women, even at older ages, produce more T cells that can prevent the virus from spreading.
The researchers summarize the study as follows: “We found that older female patients mounted significantly stronger T-cell activation against ongoing SARS-CoV-2 infection than men. More importantly, we determined that a poor T-cell response was inversely correlated with patients’ age and associated with more severe disease in male patients, but that the same association did not occur in female patients”.
Dr. Akiko Iwasaki, an immunologist at Yale University who led the study, says, “As men age, they lose the ability to stimulate and activate their T cells. If you look at patients who have lost the ability to make T cells, they are the ones who experience more severe disease”.
The study examined 17 men and 22 women hospitalized after becoming infected. People taking medication that affects the immune system and patients on ventilators could not be included. The findings show that a patient’s sex is a factor that should be considered during coronavirus vaccine development. An immunologist describes this aspect of the study as follows: “If a vaccine is developed, only one dose will be sufficient for young people and young women, whereas older men might need 3 vaccine doses. This is an important issue to consider”.
More Cases Are Seen in Children, While Mortality Remains Low
According to a report from the American Academy of Pediatrics, children represented 9.3% of all COVID-19 cases in the United States as of August 20, 2020. This proportion increased from 9.1% to 9.3% compared with the previous week, but children accounted for only 0.06% of all deaths.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.